- Presentations
- 3
- Markets
- 1
Wixela Inhub is a brand of Fluticasone propionate and Salmeterol marketed by Mylan Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Fluticasone propionate and Salmeterol
- Brand owner
- Mylan Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 100 mcg/50 mcg inhalation powder, 250 mcg/50 mcg inhalation powder, 500 mcg/50 mcg inhalation powder
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Wixela Inhub 100 mcg/50 mcg inhalation powderInhalation | Mylan Pharmaceuticals | US FDA | Available on request |
| Wixela Inhub 250 mcg/50 mcg inhalation powderInhalation | Mylan Pharmaceuticals | US FDA | Available on request |
| Wixela Inhub 500 mcg/50 mcg inhalation powderInhalation | Mylan Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Fluticasone propionate and Salmeterol.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Wixela Inhub
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.